Literature DB >> 10781600

Signaling from G protein-coupled receptors to ERK5/Big MAPK 1 involves Galpha q and Galpha 12/13 families of heterotrimeric G proteins. Evidence for the existence of a novel Ras AND Rho-independent pathway.

S Fukuhara1, M J Marinissen, M Chiariello, J S Gutkind.   

Abstract

The regulation of gene expression by cell surface receptors often involves the stimulation of signaling pathways including one or more members of the MAPK superfamily of serine-threonine kinases. Upon their activation in the cytosol, MAPKs can translocate to the nucleus and affect the activity of a variety of transcription factors. Recently, it has been observed that a novel member of the MAPK superfamily, ERK5, can be potently activated by transforming G protein-coupled receptors (GPCRs) and that ERK5 participates in the regulation of c-jun expression through the activation of MEF2 transcription factors. How cell surface receptors, including GPCRs, stimulate ERK5 is still poorly understood. In this study, we have used transiently transfected COS-7 cells to begin delineating the biochemical route linking GPCRs to ERK5. We show that receptors that can couple to the G(q) and G(12/13) families of heterotrimeric G proteins, m1 and thrombin receptors, respectively, but not those coupled to G(i), such as m2 receptors, are able to regulate the activity of ERK5. To investigate which heterotrimeric G proteins signal to ERK5, we used a chimeric system by which Galpha(q)- and Galpha(13)-mediated signaling pathways can be conditionally activated upon ligand stimulation. Using this system, as well as the expression of activated forms of G protein subunits, we show that the Galpha(q) and Galpha(12/13) families of heterotrimeric G proteins, but not the Galpha(i), Galpha(s), and betagamma subunits, are able to regulate ERK5. Furthermore, we provide evidence that the stimulation of ERK5 by GPCRs involves a novel signaling pathway, which is distinct from those regulated by Ras and Rho GTPases.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10781600     DOI: 10.1074/jbc.M002410200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

1.  A synthetic biology approach reveals a CXCR4-G13-Rho signaling axis driving transendothelial migration of metastatic breast cancer cells.

Authors:  Hiroshi Yagi; Wenfu Tan; Patricia Dillenburg-Pilla; Sylvain Armando; Panomwat Amornphimoltham; May Simaan; Roberto Weigert; Alfredo A Molinolo; Michel Bouvier; J Silvio Gutkind
Journal:  Sci Signal       Date:  2011-09-20       Impact factor: 8.192

Review 2.  Role of G12 proteins in oncogenesis and metastasis.

Authors:  Juhi Juneja; Patrick J Casey
Journal:  Br J Pharmacol       Date:  2009-04-30       Impact factor: 8.739

3.  Platelet Extracellular Regulated Protein Kinase 5 Is a Redox Switch and Triggers Maladaptive Platelet Responses and Myocardial Infarct Expansion.

Authors:  Scott J Cameron; Sara K Ture; Deanne Mickelsen; Enakshi Chakrabarti; Kristina L Modjeski; Scott McNitt; Michael Seaberry; David J Field; Nhat-Tu Le; Jun-Ichi Abe; Craig N Morrell
Journal:  Circulation       Date:  2015-05-01       Impact factor: 29.690

4.  Tumor promoting properties of a cigarette smoke prevalent polycyclic aromatic hydrocarbon as indicated by the inhibition of gap junctional intercellular communication via phosphatidylcholine-specific phospholipase C.

Authors:  Brad L Upham; Ludek Bláha; Pavel Babica; Joon-Suk Park; Iva Sovadinova; Charles Pudrith; Alisa M Rummel; Liliane M Weis; Kimie Sai; Patti K Tithof; Miodrag Guzvić; Jan Vondrácek; Miroslav Machala; James E Trosko
Journal:  Cancer Sci       Date:  2008-04       Impact factor: 6.716

5.  Nuclear effects of G-protein receptor kinase 5 on histone deacetylase 5-regulated gene transcription in heart failure.

Authors:  Yan Zhang; Scot J Matkovich; Xiujun Duan; Jessica I Gold; Walter J Koch; Gerald W Dorn
Journal:  Circ Heart Fail       Date:  2011-07-18       Impact factor: 8.790

6.  Erk5 participates in neuregulin signal transduction and is constitutively active in breast cancer cells overexpressing ErbB2.

Authors:  Azucena Esparís-Ogando; Elena Díaz-Rodríguez; Juan Carlos Montero; Laura Yuste; Piero Crespo; Atanasio Pandiella
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

Review 7.  Approaches for probing allosteric interactions at 7 transmembrane spanning receptors.

Authors:  Michael T Klein; Paige N Vinson; Colleen M Niswender
Journal:  Prog Mol Biol Transl Sci       Date:  2013       Impact factor: 3.622

8.  Undermining the endothelium by ablation of MAPK-MEF2 signaling.

Authors:  Eric N Olson
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

9.  The P2Y2 nucleotide receptor requires interaction with alpha v integrins to access and activate G12.

Authors:  Zhongji Liao; Cheikh I Seye; Gary A Weisman; Laurie Erb
Journal:  J Cell Sci       Date:  2007-05-01       Impact factor: 5.285

10.  Galpha13 regulates MEF2-dependent gene transcription in endothelial cells: role in angiogenesis.

Authors:  Guoquan Liu; Jingyan Han; Jasmina Profirovic; Elena Strekalova; Tatyana A Voyno-Yasenetskaya
Journal:  Angiogenesis       Date:  2008-12-18       Impact factor: 9.596

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.